ClinicalTrials.Veeva

Menu

Vitamin D and Critically Ill Patients

C

Chinese PLA General Hospital (301 Hospital)

Status

Completed

Conditions

Systemic Inflammatory Response Syndrome
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT01636232
CPLAGH-2012026

Details and patient eligibility

About

The higher rate of vitamin D deficiency is spotted among patients being hospitalized or in critical condition. Especially, vitamin D level below normal prolongs hospital stay and increases incidence of adverse prognosis and pushing up mortality of a number of diseases. However, it is remain unclear the relationship between vitamin D levels and critically ill, especially infection or sepsis. In this study, the investigators evaluate the significance of vitamin D for diagnosis and other relevant assessments of ICU cases, including vitamin D's relevance to sepsis, as well as its value in severity and prognosis assessment, high-performance liquid chromatography and tandem mass spectrometry was used to detect the quantification of the total 25(OH)D in serum of critically ill patients. The investigators speculate that measurement of vitamin D could be taken as an indicator for diagnosis and assessment in critically ill patients.

Enrollment

234 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male and female aged 18 years old and over;

  • Entered ICU;

  • Fulfilled at least two criteria of systemic inflammatory response syndrome

    • core temperature higher than 38 °C or lower than 36 °C
    • respiratory rate above 20/min, or PCO2 below 32 mmHg
    • pulse rate above 90/min, and
    • white blood cell count greater than 12,000/μl or lower than < 4,000/μl or less than 10% of bands.

Exclusion criteria

  • patients or their relatives refused

Trial design

234 participants in 3 patient groups

ICU sepsis group
Description:
The ICU sepsis group consisting of 105 critically-ill cases diagnosed with sepsis upon admission and sampled within the first 24h of their ICU stay.
ICU control group
Description:
the ICU control group including 51 critically-ill cases in whom sepsis was clinically excluded and from whom samples were taken upon admission.
healthy control group
Description:
the healthy control group composed of 50 healthy control outpatients. For the healthy control outpatients, possibilities of acute or past chronic diseases were excluded. Moreover, we made sure that the healthy control subjects had not been hospitalized or taken vitamin-based substitutive drugs in the last 12 months, and proved normal in physical checkups and lab examinations.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems